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DEAR EDITOR, 
Allergic reactions to polysulfone dialysis membra-
nes are uncommon. According to data from a study 
conducted in 1993 in 1536 patients from 30 dialysis 
centers, the annual incidence was 4.2 per 1000 dialysis 
treatments1. Such allergic reactions may occur imme-
diately at er the i rst contact of the membrane with the 
patient’s blood or at er a number of treatments, making 
them more dii  cult to diagnose, particularly if the cli-
nical presentation is atypical2-4. h ere are two types of 
reactions: type A (‘hypersensitive’) and type B (‘non-
specii c’). Although the etiology remains largely un-
known, the increased frequency of type A response was 
observed in patients with allergic diathesis, and type B 
is thought to be mediated by complement activation. 
Type A reactions are usually apparent immediately, at 
the very beginning of the dialysis process, whereas type 
B occurs during the i rst 15-30 minutes or later. Type A 
reactions present with itching, urticaria, angioedema 
and anaphylaxis, whereas the most common signs and 
symptoms of type B reactions are chest or back pain, 
dyspepsia, vomiting and hypotension. h e use of an-
giotensin-converting enzyme (ACE) inhibitors incre-
ases the likelihood of allergic reactions to polysulfone 
dialysis membranes5. Allergic reactions may be mild 
to life-threatening (anaphylactoid reaction, angioede-
ma, severe bronchospasm or refractory hypotension), 
or may occasionally exacerbate the symptoms of pre-
existing diseases (asthma, susceptibility to intradia-
lytic hypotension)6. Mild symptoms usually subside 
towards the end of hemodialysis (HD), and therefore 
the procedure may not need to be stopped immedia-
tely. Once apparent, the symptoms occur during each 
next contact of patient’s blood with a polysulfone dia-
lysis membrane. Cross-reactivity between dif erent 
types of synthetic dialysis membranes is also possible7.
Upon entering the era of the highly prevalent use of syn-
thetic dialysis membranes, as required by modern renal 
replacement procedures, many dialysis centers use this 
modern type of dialysis membranes exclusively. Along 
with the increasing use of synthetic membranes, we 
have noticed and recognized allergic reactions to dia-
lysis membranes that had not previously been observed 
during HD procedures using triacetate membranes.
In the last 10 years, allergic reactions to polysulfone 
membranes were identii ed in six patients at Depar-
tment of Nephrology and Dialysis, Sestre milosrdni-
ce University Hospital Center in Zagreb. Retrograde 
analysis of the following data from dialysis protocols 
was performed: type of dialysis membrane, method 
of membrane sterilization, time of symptom onset in 
relation to HD initiation, number of HD procedures 
from i rst use of incriminated membrane until dia-
gnosis, leading and accompanying symptoms, need 
of interruption of HD procedure or its continuation 
towards the end of the planned time, ACE inhibitor in 
chronic therapy, and ei  cacy of the replacement tria-
cetate membrane on the absence of symptoms. Results 
are shown in Table 1.
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Table 1.
Patients with allergic reaction to synthetic dialyzer membrane in the last 10 years at Department of Nephrology and Dialysis, 
Sestre milosrdnice University Hospital Center
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Membrane type and 
sterilization method
Elisio 17H (Nipro, 
Polynephron, gamma 
radiation)
Elisio 17H (Nipro, 
Polynephron, 
gamma radiation)












Symptom onset 15-90 min since start of HD
15-30 minssince 
start of HD
60-90 min since 
start of HD
1-5 min since start of 
4th HD
During the 1st hour 
of HD




After 7 HD procedures
After 10 HD 
procedures
After 12 HD 
procedures
Immediately
During 2nd HD 
procedure
During 2nd HD 
procedure
Leading symptom Worsening of dyspnea Chest tightness
Colicky abdominal 
pain
























7th HD 10th HD 18th HD Immediately 2nd HD 2nd HD
Effect of membrane 
replacement
(Nipro, Surefl ux, 
cellulose triacetate)
Immediate Immediate Immediate Immediate Immediate Immediate
A severe anaphylactoid reaction occurred in a sin-
gle patient (Patient 4) at er three HD procedures 
with the same dialyzer had already been perfor-
med without any symptoms. All other patients had 
milder forms of allergic reactions. Apart from the 
clinical picture, an important role in establishing 
the diagnosis lies in the patient’s ability to associa-
te the symptom onset with the initiation of HD.
In one patient (Patient 3), due to advanced psycho-
organic syndrome and reduction of cognitive functi-
ons, verbalization of previously known polymorphic 
symptoms (chronic obstructive pulmonary disease, 
asthma, abdominal angina, intradialytic hypotension) 
was inadequate. h erefore, the correct diagnosis of 
allergic reaction to polysulfone membrane was made 
at er 18 HD procedures had already been performed, 
each using a polysulfone membrane. In this patient, 
HD procedures were previously performed using 
triacetate dialysis membranes. It was only during clo-
se supervision of this patient in inpatient conditions 
that the absence of symptoms of asthma and abdomi-
nal pain was noted, except for the i rst hour of HD. 
Upon reinstating the triacetate dialysis membrane, 
the aforementioned symptoms became absent. At er 
one month, HD was accidentally initiated with a po-
lysulfone membrane, with the symptoms reappearing, 
thus coni rming the diagnosis of an allergic reaction.
h is case of a patient with reduced cognitive functions 
imposes the question of recognizing allergic reactions 
to polysulfone membranes in unresponsive, critically 
ill patients on continuous renal replacement therapy 
(CVVHD/HDF), using modern dialysis systems with 
only highly permeable, highly ef ective synthetic dia-
lysis membranes. In such patients, it is almost impo-
ssible to discern whether worsening of the symptoms 
upon initiation of renal replacement therapy is the re-
sult of allergy to the dialysis membrane or of exacer-
bation of the pre-existing disease. Apart from carefully 
monitoring the patient’s clinical condition, vital and 
hemodynamic parameters in critically ill patients in 
which renal replacement therapy has been initiated, 
timely recognition of deterioration of respiratory fun-
ction with arterial hypotension refractory to standard 
treatment procedures, or possible dermatologic mani-
festations, there is no reliable, accurate or fast diagno-
stic tool for establishing the diagnosis of an allergic re-
action to the synthetic dialysis membrane. In order to 
raise suspicion of an allergic reaction in such patients, 
substantial clinical experience of nephrology and in-
tensive medical teams is necessary for the diagnosis 
to be quickly established only with replacement of the 
dialysis membrane by that made of semi-synthetic ma-
terial, at er which the symptoms would recede8. Since 
most modern continuous renal replacement therapy 
systems (CVVHD/HDF) have a factory-integrated 
synthetic membrane inseparable from the rest of the 
extracorporeal circuit system and therefore irreplace-
able with a dialyzer of some other material, there is a 
clear limitation for dialysis treatment of such patients. 
By integrating the dialyzer into the extracorporeal 
circuit, manufacturers of such sophisticated devices 
(PRISMAFlex®System Gambro) provide almost ideal 
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conditions of continuous renal replacement therapy, 
as well as ensure the sale of their original dialyzers. 
However, as such they are unusable for treatment of 
those critically ill and allergic to synthetic membranes. 
h ere are few machines for continuous renal replace-
ment therapy that allow the use of dif erent types of 
dialyzers, and those of dif erent manufacturers, that 
can be linked to the original extracorporeal circuit 
system, dialysate circuit and replacement l uid circuit 
for the particular device (MultiFiltrate-Fresenius, Pla-
sauto Σ-Asahi Kasei, Diapact® CRRT system B. Braun).
In order to conduct a method of continuous renal 
replacement therapy, primarily CVVHDF, high-l ux 
dialysis membranes with ultrai ltration coei  cient >20 
mL/h/mm Hg are required.
Only a few non-synthetic, non-polysulfone membra-
nes have such properties, such as cellulose triacetate 
membranes (Surel ux UX-Nipro, Tricea G-Baxter, 
ACE SY-MC Assomedica SRL) with UFC >35 mL/h/
mm Hg. h ey are used almost exclusively for high-l ux 
HD and hemodiai ltration (HDF). Although some 
studies have pointed to the triacetate high-l ux mem-
brane as a possible alternative to synthetic membranes 
for continuous renal replacement therapy, it has not 
been widely implemented9.
Despite good biocompatibility, high-l ux and high-ef-
i ciency, triacetate membranes have no ability to ad-
sorb the inl ammatory mediators, have lower per-
meability for large molecules than modern synthetic 
membranes, and are not nearly as good as synthetic 
membranes in the treatment of patients with sepsis. 
h at is why there are no studies of their ef ectivene-
ss in the treatment of such patients. Although the era 
of mass use of triacetate membranes has passed, with 
superior polysulfone membranes widely available, 
triacetate membranes have gained value precisely in 
the treatment of polysulfone-hypersensitive patients.
h e critically ill with established allergy to synthetic 
membranes can therefore be treated only by intermi-
ttent HD/HDF or one of the hybrid methods, using 
high-permeability triacetate membranes (UFC >20 
mL/h/mm Hg). h e inability to perform bedside in-
termittent HD/HDF in intensive care units due to 
technical dei ciencies (absence of central water su-
pply system for dialysis or portable reverse osmosis) 
complicates the work of medical staf  and exposes 
the patient to the risk of transport to a dialysis center.
Due to the unpredictability of sometimes life-threate-
ning allergic reactions, possible cross-reactivity to di-
f erent types of polysulfone membranes, each dialysis 
center should have at least two dif erent types of dia-
lysis membranes available at any time. h e triacetate 
membrane serves both as a diagnostic tool and as the 
only option for dialysis treatment of patients allergic 
to polysulfone membranes.
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